Robert Cogger-Ward
With expertise spanning synthetic biology, clinical diagnostics and agritech, Rob supports scientist-founders, academic institutions and biotech companies in turning ideas into real-world impact.
Rob works closely with a range of clients, from early-stage companies to multinationals, to identify and protect intellectual property (IP), build robust IP strategies and prepare for fundraising. He also supports investors with IP due diligence to help safeguard their investments.
Throughout his undergraduate degree, PhD and summer studentships at the University of Leeds, he developed extensive technical experience in microbiology, cell biology, genetics, structural biology and drug discovery.
Rob regularly delivers IP education sessions to students and academics, mentors through organisations such as Science Entrepreneur Club, Forest City SynBio and Nucleate, and speaks at careers events, including one hosted at The Royal Society.
- Drafting patent applications for advanced DNA-based, genetic and engineering biology technologies
- Conducting IP due diligence for investors and supporting founders ahead of funding rounds
- Performing freedom to operate and patent landscape analyses
- Delivering IP education sessions for academic scientists and start-up founders
- PhD, Molecular Microbiology, University of Nottingham
- MSci, Biology, University of Nottingham
We were highly impressed with how quickly and accurately Rob assessed the various aspects of our product that required protection. His insights are excellent, and he consistently delivers sound business and legal guidance. We truly appreciate his enthusiasm and efficiency during our collaboration.
About Robert
Experience
Areas of expertise
Qualifications
Testimonials
Awards
How We Live Our Values: Ambition
Among my early-stage clients, one cancer therapeutics company stands out. When I first met them, they were a two-person team with an idea, some early proof-of-concept experiments, and a lab squeezed into a shipping container.
They’ve since been through multi-million-pound fundraising rounds and completed a ground-breaking in vivo proof-of-concept study.
By providing a clear and comprehensive IP strategy, and drafting a strong initial patent filing at a critical time, I was able to help the company become the success it is today.
In My Own Words
Like most people who start a PhD, I came into science wanting to improve the world. And like many who finish one, I realised that real-world impact doesn’t happen in the lab alone.
Now, I use my skills to translate wild ideas into commercial realities that are making fashion and construction more sustainable with bio-based materials, improving patient outcomes with better therapies and diagnostics, and helping secure the future of our food supply.
When people ask, “Do you miss academia?” I know my answer.
Related News
.jpg)
The Cali Fund and DSI: What life sciences and biotech companies need to know now
.avif)
New crop protection molecules: addressing agricultural challenges
Agri-informatics: Protecting data science innovation in agriculture
.avif)
What does the future hold for regenerative agriculture?
.avif)
Synthetic biology: A sustainable future for crop protection molecules
